Develop a perioperative glycemic control protocol: pre-op optimization, intra-op insulin…
- User
Develop a perioperative glycemic control protocol: pre-op optimization, intra-op insulin strategies, post-op monitoring, hypoglycemia prevention, and discharge planning.
- Assistant
Perioperative Glycemic Control Protocol
This protocol is designed for adult patients with diabetes (type 1, type 2, or steroid-induced) undergoing surgery. It aligns with ADA, Endocrine Society, and SCCM guidelines, targeting blood glucose (BG) 140-180 mg/dL perioperatively to minimize hyperglycemia, hypoglycemia, infections, and wound complications. Individualize based on patient factors (e.g., renal function, nutrition status). Involve multidisciplinary team: endocrinology, anesthesia, surgery, nursing.
Key Targets:
- BG: 140-180 mg/dL (intra- and post-op).
- Avoid hypoglycemia (<70 mg/dL); treat <100 mg/dL if symptomatic.
- Hyperglycemia threshold for intervention: >180 mg/dL.
Monitoring: Point-of-care (POC) capillary BG every 1-2 hours intra/post-op; continuous glucose monitoring (CGM) if available. Arterial BG if critically ill.
1. Pre-Op Optimization (Day Before to Day Of Surgery)
Goal: Achieve euglycemia, reduce elective surgery cancellations.
-
Elective Surgery Screening (Outpatient, 1-4 Weeks Pre-Op):
HbA1c Recommendation <8% Proceed. 8-9% Optimize with endocrinology consult; delay if uncontrolled. >9% Delay elective surgery; urgent/emergent proceed with protocol. -
Medication Adjustments (Hold/Reduce Day Before/Of Surgery):
Agent Adjustment Long-acting insulin (e.g., glargine) Reduce 20-50% evening before; 80% basal morning of (type 2); full basal if NPO <24h (type 1). Short-acting insulin Hold if BG <140 mg/dL; dose 70-80% if >140. Oral agents/SGLT2i/GLP-1 Hold day before/from morning of (risk DKA/euglycemic DKA). Metformin Hold day of if contrast/CT. -
Fasting Orders: Clear liquids until 2h pre-op; carbohydrate loading (e.g., 50g CHO drink) if BG stable to prevent ketosis.
-
Pre-Op BG Check: On arrival; if >250 mg/dL (type 1) or >300 mg/dL (type 2), delay non-emergent; start IV dextrose/insulin.
-
Patient Education: Hypoglycemia symptoms, glucagon kit if type 1.
2. Intra-Op Insulin Strategies
Goal: Tight control with IV insulin infusion (IIR) to match variable surgical stress.
-
Initiation:
- Start IIR if BG >180 mg/dL pre-induction or expected hyperglycemia.
- Use D5NS (or D10NS if high dextrose needs) at 100 mL/h maintenance IV fluids.
-
Yale Insulin Infusion Protocol (Validated, Adjustable):
BG (mg/dL) IIR Rate (units/h) Dextrose Adjustment <100 0 (off); bolus 0.5u if <70 Increase D5NS to 150 mL/h 100-139 0.5 D5NS 100 mL/h 140-180 1.0 D5NS 100 mL/h 181-220 1.5 D5NS 100 mL/h 221-270 2.0 D5NS 100 mL/h 271-320 3.0 D5NS 100 mL/h >320 4.0 + bolus 2-4u D5NS 100 mL/h - Titration: Check BG q30-60min; adjust every 1h. Bolus = 0.1u/kg if >50 mg/dL rise.
- Transition: Taper IIR when PO intake resumes; overlap with SQ basal insulin x2-4h.
-
Anesthesia Considerations: Dexamethasone → add basal insulin; TPN → add insulin to bag.
3. Post-Op Monitoring (PACU to Floor/ICU)
Goal: Prevent rebound hyperglycemia/hypoglycemia during stress/nil per os (NPO) phase.
-
Frequency:
Setting BG Checks PACU/ICU q1h x4, then q2h if stable Floor q4-6h; q2h if >180 or on IIR Eating qAC/pre-meal + 2hPC -
Insulin Regimen:
NPO Eating Continue IIR (target 140-180); add basal SQ when stable. Basal-bolus: Basal 0.2-0.5u/kg/d; prandial 1u/10-15g CHO or correction scale. -
Correction Scale Example (per 20kg body weight):
BG (mg/dL) Correction Dose (units) 181-220 2 221-270 4 271-320 6 >320 8 + recheck 1h -
Steroids/Nutrition: Increase basal 20-50% for dexamethasone; insulin:CHO ratio for tube feeds.
4. Hypoglycemia Prevention
Goal: BG >70 mg/dL; zero tolerance in vulnerable patients (elderly, renal failure).
-
Proactive Measures:
- Never skip basal insulin (critical in type 1).
- Co-infuse dextrose with IIR (D5 ≥100 mL/h).
- Frequent BG (q1h if <140).
- CGM alarms at 100 mg/dL.
-
Treatment Protocol (15-15 Rule):
- BG <70: 15g fast CHO (juice/glucose tabs) → recheck 15min.
- If <70 still: Repeat 15g → if NPO, 0.5-1g/kg D50 IV (max 50mL).
- Once >70: CHO + protein meal; hold insulin 20-50%.
- Severe (<40 or neuro sx): Glucagon 1mg IM/ SQ or IV dextrose.
-
Root Cause Review: Daily huddle for hypos; adjust protocol.
5. Discharge Planning
Goal: Seamless transition to outpatient control; prevent readmissions.
-
Criteria for Discharge:
- BG stable 140-180 x24h on SQ regimen.
- Tolerating PO; HbA1c plan.
-
Steps:
- Medication Reconciliation: Restart pre-op agents (adjust based on post-op needs); bridge with basal if needed.
- Education (Teach-Back):
- SMBG qAC/pre-meal + HS; target 80-180.
- Hypo recognition/treatment kit.
- Sick day rules (e.g., hold SGLT2i).
- Follow-Up: PCP/endocrinology within 1 week; HbA1c in 3 months.
- High-Risk Flags: Type 1, post-DKA, readmit risk → home health/CGM.
-
Hand-Off Tool: EMR note with last BG, insulin total daily dose (TDD), regimen.
Implementation Notes:
- Staff Training: Annual competency.
- Audit: Monthly BG metrics (<5% hypo, 70-80% in target).
- Exceptions: Consult endocrinology for gestational diabetes, transplant, etc.
This protocol reduces complications by 20-30% per literature. Customize locally.